Discover the critical elements that influence stroke recovery outcomes, from timing of treatment to rehabilitation approaches ...
In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback